Delays in Access Hurt Everyone.

Rate of Availability

The average Rate of Availability for all products approved in the EU hovers around 47%, dropping to 37% in orphan conditions.

Time to Availability

The Average Time to Availability for those products is a staggering 511 days across all products, and 636 for orphan therapies.

15 Million USD per Day

According to Patheon research, delays in launch can cost manufacturers as much as $15 million per day!
Empty space, drag to resize

We can do better.

Access Strategy in Context of Audience and Environment.

Almost 60% of pharmaceutical companies cite “Market Access challenges” as their biggest barrier to successful launches.

So, how do we help develop winning launch strategies that drive accelerated patient access?
Empty space, drag to resize
Write your awesome label here.

Work With Advisors Who Know, From Experience.

Close the gap between technical knowledge, and applicable insights that drive adoption.

Write your awesome label here.
Write your awesome label here.
Write your awesome label here.
Write your awesome label here.
Write your awesome label here.
Write your awesome label here.
product & portfolio planning 
Early Market Research
Landscape Assessments
Labeling Strategy
Portfolio Plans
Asset Forecasts
Early Segmentation Strategy
Base Case Assumptions
Go/No-Go Decision Support
Evidence generation planning
Clinical Trial Design
Economic Modelling
Clinical Outcomes Assessment Strategy
RWE Strategy
HTA Strategy and Submissions
TPP Testing
Value Strategy & Narrative Testing
pricing & Reimbursement strategy
Portfolio Pricing Strategy
Payer Segmentation
Reimbursement & Coding
Contracting
Value-Based Opportunity Assessments
Product Distribution Channels
Formulary Dossier Preparation 
Pricing & Reimbursement Thresholds
Policies & Pathways Research
Clinical Guidelines
Clinical Pathway Research
Payer/Funding Pathways
National/International Policy Impact: IRA, EU JClA
Advocacy Landscape Assessments
Patient & Provider Advocacy Strategy
Write your awesome label here.

Define Value In Context of Audience & Environment

We believe a customer-centric strategy is the key to achieving optimal patient access and we’ve built a network of more than 700 Payer Advisors who agree!

Our expert Clinical & Economic Advisors have worked for Payer organizations at the National, Regional, and Local levels. Now, they help you align to the 5 key elements critical to addressing stakeholders' needs - in context of each audience and environment.

Stakeholder Insights & Validation

Patients' access to your therapies heavily depends on stakeholders' perceived clinical benefits and differentiation from other options. CDP will help identify the key decisions that influence adoption and use this to create project roadmaps that capitalize on your unique advantages.  
Write your awesome label here.

Develop Winning Go-to-Market Roadmaps

High-performing launches happen when teams execute consistently across countries, regions, and local institutions. Make sure your entire cross-functional team knows the playbook, and their part in achieving the big picture goals.

One Contract. Access Everything.

CDP operates under a credits-based model. Clients can purchase an allotment of credits, usable anytime in a 24-month period for use across any of our services.
Write your awesome label here.
Write your awesome label here.
Write your awesome label here.

CDP Strategy

Product & Portfolio Strategy
+ Readiness Assessments
+ Materials Review
+ SWOT Analysis
+ Readiness Heatmap
+ Custom Access Workshops
+ Stakeholder Validation
+ Monthly Governance Sessions

CDP Engage

Stakeholder Engagement
+ Pronto: calls over Zoom with Payer-Advisors in as little as 48 hrs
+ Validate: Double Blinded Research in just 10 days
+ Focus: Peer-led Virtual Ad Boards
+ Strategy Sessions: Scenario role play w Payer-Advisors

CDP Roadmaps

Planning & Governance
+ SmartAccess software for tracking unlimited products/indications
+ Mentor-led workshops to navigate high-probability, high-impact scenarios
+ 12 follow-up Mentoring Sessions to help respond to scenarios addressed in the workshops

Our Leadership Team

Nick DeJesus
President & Managing Partner,
 CDP Engage
Empty space, drag to resize
Nick has been a Customer Strategy & Stakeholder Engagement Advisor to more than 30 launch brands with a "value in context" approach.

He's managed more than 500 projects across Payer, Provider, and Patient engagement for Oncology, Virology, Neurology, Metabolic, Ophthalmology, Rare, Cell & Gene Therapies.


Contact Nick for details on CDP Engage or Roadmaps  @ ndejesus@cdpmentor.com

Nikos Georgiades, Ph.D
Chief Strategy Officer & Managing Partner,
CDP Strategy
Empty space, drag to resize
Nikos brings 20 years' experience as a global launch leader, focusing on biopharma commercialization, operations, data and digital technology.​​

His expertise spans late-stage development through post-launch commercialization and has led sales and marketing organizations, establishing global launch readiness capabilities across Novartis as well as McKinsey.

Contact Nikos for details on CDP Strategy or Roadmaps @ ngeorgiades@cdpmentor.com​

Jeff Greenhouse
Chief Operating Officer & Managing Partner,
Launch Academy
Empty space, drag to resize
Jeff is a Strategic Advisor to CEOs and Corporations with a focus on maximizing the value of their data and enabling their teams to pull actionable insights from it.

His 25 years' experience as an analytics executive, agency owner, entrepreneur and trainer have created data-driven value across numerous industries, from startups to global, public companies. 


Contact Jeff for details on Launch Academy
@ jgreenhouse@cdpmentor.com